326 related articles for article (PubMed ID: 34091256)
1. Patterns of mental health service use among Medicaid-insured youths treated by nurse practitioners and physicians: A retrospective cohort study.
Yang BK; Idzik S; Evans P
Int J Nurs Stud; 2021 Aug; 120():103956. PubMed ID: 34091256
[TBL] [Abstract][Full Text] [Related]
2. Comparing Nurse Practitioner and Physician Prescribing of Psychotropic Medications for Medicaid-Insured Youths.
Yang BK; Burcu M; Safer DJ; Trinkoff AM; Zito JM
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):166-172. PubMed ID: 29641238
[No Abstract] [Full Text] [Related]
3. Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort.
Pennap D; Zito JM; Santosh PJ; Tom SE; Onukwugha E; Magder LS
JAMA Pediatr; 2018 Jun; 172(6):576-584. PubMed ID: 29710205
[TBL] [Abstract][Full Text] [Related]
4. Access to Psychosocial Services Prior to Starting Antipsychotic Treatment Among Medicaid-Insured Youth.
Finnerty M; Neese-Todd S; Pritam R; Leckman-Westin E; Bilder S; Byron SC; Hudson Scholle S; Crystal S; Olfson M
J Am Acad Child Adolesc Psychiatry; 2016 Jan; 55(1):69-76.e3. PubMed ID: 26703912
[TBL] [Abstract][Full Text] [Related]
5. Mental Health Service Use by Medicaid-Enrolled Children and Adolescents in Primary Care Safety-Net Clinics.
Cummings JR; Ji X; Druss BG
Psychiatr Serv; 2020 Apr; 71(4):328-336. PubMed ID: 31960778
[TBL] [Abstract][Full Text] [Related]
6. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
Harpaz-Rotem I; Rosenheck RA
Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
[TBL] [Abstract][Full Text] [Related]
7. Rising prevalence of antidepressants among US youths.
Zito JM; Safer DJ; DosReis S; Gardner JF; Soeken K; Boles M; Lynch F
Pediatrics; 2002 May; 109(5):721-7. PubMed ID: 11986427
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic Polypharmacy Among Youths With Serious Emotional and Behavioral Disorders Receiving Coordinated Care Services.
Wu B; Bruns EJ; Tai MH; Lee BR; Raghavan R; dosReis S
Psychiatr Serv; 2018 Jun; 69(6):716-722. PubMed ID: 29540121
[TBL] [Abstract][Full Text] [Related]
9. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
dosReis S; Owens PL; Puccia KB; Leaf PJ
Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.
Zito JM; Burcu M; Ibe A; Safer DJ; Magder LS
Psychiatr Serv; 2013 Mar; 64(3):223-9. PubMed ID: 23242390
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
12. Continuity of Care and Mental Health Service Use Among Medicaid-enrolled Youths.
Pennap D; Zito JM; Santosh PJ; Tom SE; Onukwugha E; Magder LS
Med Care; 2020 Mar; 58(3):199-207. PubMed ID: 32106164
[TBL] [Abstract][Full Text] [Related]
13. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
[TBL] [Abstract][Full Text] [Related]
14. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
[TBL] [Abstract][Full Text] [Related]
15. Provider-Level Caseload of Psychosocial Services for Medicaid-Insured Children.
Harati PM; Cummings JR; Serban N
Public Health Rep; 2020; 135(5):599-610. PubMed ID: 32645279
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
Martin A; Leslie D
Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
[TBL] [Abstract][Full Text] [Related]
18. Access to Primary, Mental Health, and Specialty Care: a Comparison of Medicaid and Commercially Insured Populations in Oregon.
McConnell KJ; Charlesworth CJ; Zhu JM; Meath THA; George RM; Davis MM; Saha S; Kim H
J Gen Intern Med; 2020 Jan; 35(1):247-254. PubMed ID: 31659659
[TBL] [Abstract][Full Text] [Related]
19. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.
Medhekar R; Fujimoto K; Aparasu RR; Bhatara VS; Johnson ML; Alonzo JP; Schwarzwald HL; Chen H
J Manag Care Spec Pharm; 2019 Jan; 25(1):29-38. PubMed ID: 30589632
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Children Diagnosed With Attention-Deficit/Hyperactivity Disorder and 30-Day Follow-up Care With Practitioners Among Medicaid Recipients in Georgia.
Yin H; Ibe B; Parr TL; Csukas S; Jones BL; Thompson S
Qual Manag Health Care; 2022 Jul-Sep 01; 31(3):154-159. PubMed ID: 34571512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
